Abstract: A method of detecting lung cancer in a subject involves: a) determining in a serum sample, the expression level of one or more miRNAs; b) determining in a urine sample, the concentration of one or more metabolites; c) comparing the expression level of the one or more miRNAs with the expression level of the one or more miRNAs in a normal control; d) comparing the concentration of the one or more metabolites with the concentration of the one or more metabolites in a normal control; e) determining whether the subject has lung cancer in accordance with the result of steps (c) and (d); wherein a difference in the expression level of the one or more miRNAs relative to the expression level of the normal control, and a difference in the concentration of the one or more metabolites relative to the concentration of the normal control, are indicative of lung cancer; and f) treating the subject with a cancer management program based on the determination in step (e).

Abstract: A radiotherapy system is configured to determine in vivo dose deposition of a radiotherapy treatment beam. The system includes the following components. A bi-planar magnetic resonance imaging (MRI) apparatus comprising a pair of spaced apart magnets. One of the magnets includes a hole proximal the centre thereof. A treatment beam source configured to generate a radiotherapy treatment beam. The treatment beam source is positioned to transmit the treatment beam through the hole in the magnet. A patient support configured to position a patient with the system so that a treatment target is proximal the treatment beam. A Positron Emission Tomography (PET) detector configured to obtain PET data of the treatment beam impacting the patient. The PET detector is positioned so that a transverse section of the patient that includes the treatment target lies between opposing portions of the PET detector.

Abstract: A magnetic resonance (MR)-radiotherapy (RT) hybrid system for treating a patient is disclosed. The MR-RT hybrid system comprises: an MR imaging (MRI) apparatus comprising bi-planar magnets configured to generate a magnetic field; a radiation source configured to supply a radiation beam to treat the patient; a gantry configured to couple the MR apparatus at a first end and the radiation source so that they can rotate in unison; a treatment support configured to support the patient; a motor configured to move the treatment support; and a controller. The controller comprises a processor and memory having stored thereon instructions, which when executed by the processor, cause the motor to move the treatment support in order to avoid collision between the MRI apparatus and the patient when the MRI apparatus is rotated. A method for positioning the treatment support within the MR-RT hybrid system is also disclosed.

Abstract: A magnetic resonance imaging (MRI) and radiation therapy system is described. The system has a magnet gantry, an MRI apparatus, a patient support system and a radiation source head. The magnet gantry is configured to rotate about a magnet gantry axis. The MRI apparatus is coupled to the magnet gantry. The radiation source head is coupled to the MRI apparatus via a radiation source arm. The radiation source head is configured to emit a treatment beam at varying angles with respect to an azimuthal gantry axis. A method for performing stereotactic radiosurgery (SRS) using a magnetic resonance (MR)-SRS is also described.

Abstract: Colchicine derivative(s), method(s) and use(s) thereof for treatment of inflammation.

Abstract: A magnetic resonance (MR)-radiotherapy (RT) hybrid system for treating a patient is disclosed. The MR-RT hybrid system includes a radiation source for supplying a radiation beam to treat the patient and an MR imaging (MRI) apparatus for generating a divergent gradient field shaped to match a divergent geometry of the radiation beam of the radiation source.

Abstract: A metamaterial liner for an MRI bore. The metamaterial liner may cover only a portion of the MRI bore, allowing travelling wave excitations within the lined portion. By restricting the waves to the lined portion, improved signal to noise ratio may be provided. The lined length may be adjustable, for example by forming the metamaterial liner of removable annular segments. A method is provided of adjusting the length of the lined portion by removing metamaterial segments. The segments may be included in interchangeable modules. The MRI liner is suitable for any magnetic field strength, and in particular may provide improved signal to noise at reduced technical difficulty at magnetic field strengths between conventional field strengths suitable for a birdcage coil and conventional travelling wave field strengths.

Abstract: There is described herein compounds, compositions and methods for inducing synthetic lethality in a cancer cell(s).

Abstract: The present invention generally relates to use of compounds and compositions as a chemosensitizers and/or radiosensitizers and/or inhibitors of PNKP phosphatase activity. The present invention provides pharmaceutical combinations and/or a pharmaceutically acceptable salt thereof, kits containing such compounds and/composition and methods of using such compounds and/or compositions.

Abstract: A liner for a bore of a waveguide is provided. The liner as an aperture passing through it and is formed of a metamaterial that has a relative electrical permittivity that is negative and near zero. When the liner is installed in the waveguide, it lowers the cutoff frequency of the waveguide while allowing the waveguide to remain hollow. This liner can be used in the bore of an MRI machine to lower the cutoff frequency of the bore of the MRI machine to allow the MRI machine to operate using waves having a lower frequency that if the liner was not used.

Abstract: A radiation therapy system comprises a radiation source generating a beam of radiation and a magnetic resonance imaging apparatus. An interface acts between the radiation source and the MRI apparatus that permits irradiation to be performed simultaneously with imaging. The MRI apparatus and radiation source are coupled such that the system can be used in a rotation mode whereby the radiation source can irradiate a subject from basically any angle without reducing MRI image quality.

Abstract: A computer-implemented method is provided for reducing artifacts in an MRI image as a result of radiation induced current in collector coils of an MRI apparatus. The method comprises the following steps. Selecting a plurality of pixels in a k-space image prior to generation of the MRI image. Analyzing each of the plurality of selected pixels to determine whether a pixel intensity is greater than a predefined global threshold. For each pixel having pixel intensity greater than the predefined global threshold, determining whether the pixel lies within a signal region of the k-space image or outside of the signal region of the k-space image. For each pixel that lies outside of the signal region, modifying the pixel intensity to be similar to a background pixel intensity, thereby creating a modified k-space image. Generating the MRI image based on the modified k-space image. A non-transitory computer readable medium and a radiation therapy system configured to implement the method are also provided.

Abstract: Disclosed herein is a magnet assembly that includes at least two magnets arranged in a fixed spaced relationship with one another thereby to define a space between the magnets that encompasses an imaging volume. Each of the magnets produces a variety of magnetic field strengths across inward-facing surfaces thereof that, in combination, produce an acceptably homogeneous magnetic field in the imaging volume. Also disclosed is a method of defining a magnetic field for an imaging volume. The method comprises generating an initial model of a magnet assembly; estimating a magnetic field for the imaging volume based on the model; calculating deviation between the estimated magnetic field and a target magnetic field for the imaging volume; and updating the model to reduce the deviation by modifying the magnet assembly to produce a variety of magnetic field strengths that, in combination, produce substantially the target magnetic field in the imaging volume.

Abstract: An apparatus and method is provided for characterizing adhesive bonding using an acoustic wave MEMS sensor. The sensor can consist of a silicon substrate, a thin aluminum nitride film on top of the substrate and a thin gold film above the aluminum nitride layer. An adhesive layer is added on top of the sensor and the dispersion property of acoustic waves in the layered configuration can be utilized for bonding integrity characterization. A wave dispersion model is developed to study the effect of changing the interface stiffness on the wave dispersion profile and to investigate the sensitivity of different sensor configurations. The results of the model illustrate that the dispersion profile shifts in the direction of decreasing wave velocity as the interface stiffness decreases.

Abstract: There is described herein compounds, compositions and methods for inducing synthetic lethality in a cancer cell(s).

Abstract: The present invention generally relates to use of compounds and compositions as a chemosensitizers and/or radiosensitizers and/or inhibitors of PNKP phosphatase activity. The present invention provides pharmaceutical combinations and/or a pharmaceutically acceptable salt thereof, kits containing such compounds and/composition and methods of using such compounds and/or compositions.

Abstract: A computer-implemented method is provided for reducing artefacts in an MRI image as a result of radiation induced current in collector coils of an MRI apparatus. The method comprises the following steps. Selecting a plurality of pixels in a k-space image prior to generation of the MRI image. Analysing each of the plurality of selected pixels to determine whether a pixel intensity is greater than a predefined global threshold. For each pixel having pixel intensity greater than the predefined global threshold, determining whether the pixel lies within a signal region of the k-space image or outside of the signal region of the k-space image. For each pixel that lies outside of the signal region, modifying the pixel intensity to be similar to a background pixel intensity, thereby creating a modified k-space image. Generating the MRI image based on the modified k-space image. A non-transitory computer readable medium and a radiation therapy system configured to implement the method are also provided.

Abstract: Taxanes are widely used in the treatment of breast cancer, although there are currently no validated predictive markers for taxane responsiveness. While the mechanism by which taxanes induce mitotic arrest is well documented, the signaling pathway that links mitotic arrest to cell death, is ill-defined. As described herein, the BH3-only protein Bad and Bik are prognostic indicators for overall survival after adjuvant taxane chemotherapy and a predictive marker for taxane responsiveness.

Abstract: A radiation therapy System comprises a magnetic resonance imaging (MRI) apparatus and a linear accelerator capable of generating a beam of radiation. The linear accelerator is immersed in and oriented with respect to the MRI magnetic field to expose the linear accelerator to magnetic force that directs particles therein along a central axis thereof.

Abstract: Provided in the following specification are precursors or synthons that are useful for the synthesis of various arabinose based chemical and radiochemical derivatives of nitroimidazole-containing azomycin arabinosides, such as radioiodinated 1-#-D-(5-deoxy-5-[I*]-iodoarabinofuranosyl)-2-nitroimidazole (*IAZA), and radiofluorinated 1-#-D-(5-deoxy-5-[18F]-iodoarabinofuranosyl)-2-nitroimidazole (18FAZA). Such compounds are useful in imaging, therapy, or radiotherapy. Further, various syntheses of said precursors/synthons and the incorporation of said precursors/synthons into kits is provided. The precursors/synthons provided herein allow for an improved and facile manufacturing process for nitroimidazole-containing azomycin arabinosides.